A carregar...
The role of enasidenib in the treatment of mutant IDH2 acute myeloid leukemia
Recurrent mutations affecting cellular metabolism and epigenetic regulation are implicated in the pathogenesis of acute myeloid leukemia (AML). Isocitrate dehydrogenase 2 (IDH2) gene mutations are described in 12% of patients with AML and 5% of patients with myelodysplastic syndromes. IDH2 enzyme is...
Na minha lista:
| Publicado no: | Ther Adv Hematol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6041864/ https://ncbi.nlm.nih.gov/pubmed/30013764 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620718777467 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|